The trading price of Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX) closed higher on Thursday, March 29, closing at $1.62, 88.59% higher than its previous close.
In examining the 52-week price action we see that the stock hit a 52-week high of $66.00 and a 52-week low of $0.72. Over the past month, the stock has gained 22.73% in value.
Biodexa Pharmaceuticals Plc ADR, whose market valuation is $0.39 million at the time of this writing. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by $0 per share this quarter, however they have predicted annual earnings per share of $0 for 2019 and $0 for 2020.
Analysts have forecast the company to bring in revenue of $240k for the current quarter, with the likely lows of $240k and highs of $240k.
A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of Biodexa Pharmaceuticals Plc ADR No upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest BDRX has a 50% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Sell, while an average of long term indicators suggests that the stock is currently 100% Sell.
A quick review shows that BDRX’s price is currently 39.48% off the SMA20 and 12.92% off the SMA50. The RSI metric on the 14-day chart is currently showing 62.60, and weekly volatility stands at 22.48%. When measured over the past 30 days, the indicator reaches 10.00%. Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX)’s beta value is currently sitting at 1.43, while the Average True Range indicator is currently displaying 0.20.
To see how Biodexa Pharmaceuticals Plc ADR stock has been performing in comparison to its peers in the industry, here are the numbers: BDRX stock’s performance was 88.59% in the latest trading, and -95.92% in the past year.
An evaluation of the daily trading volume of Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX) indicates that the 3-month average is 619.15K. However, this figure has increased over the past 10 days to an average of 9.97 million.
Currently, records show that 0.24 million of the company’s shares remain outstanding. The institutions hold 38.64%. The stats also highlight that short interest as of Mar 15, 2024, stood at 0.1 million shares, resulting in a short ratio of 0.26 at that time. From this, we can conclude that short interest is 2.42% of the company’s total outstanding shares. It is noteworthy that short shares in March were down slightly from the previous month’s figure, which was 0.24 million. However, since the stock’s price has seen -39.55% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
